ConductScience.org, home

Paper20147573

A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis.

Fallon P and 1 other. J Psychopharmacol, 2011. Cited by 45 papers, by iCite.

Cite this record

ConductScience Library. A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis. Papers, record 20147573. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20147573

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis.
PubMed
Journal
J Psychopharmacol
PubMed
Year
2011
PubMed
Publication types
Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
45
iCite
Relative citation ratio, by iCite
1.81
iCite
Revised in PubMed
2011-06-02
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fallon PPaul
2Dursun SMSerdar M

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antipsychotic AgentsMajor topic
Drug ToleranceMajor topic
Movement DisordersMajor topic
SchizophreniaMajor topic
Adult
Age Factors
Cohort Studies
Dose-Response Relationship, Drug
Female
Humans
Life Change Events
Male
Middle Aged
Recurrence
Sex Factors

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
RDO/33/94Department of HealthUnited KingdomPubMed

Source PubMed

Download CSV of grants

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.

PMIDTitleJournalYearIn PapersSource
42397413Dopamine supersensitivity psychosis: a critical evaluation of diagnostic validators.J Neural Transm (Vienna)2026https://conductscience.org/library/papers/42397413PubMed
34355232
Predictors of Lack of Relapse After Random Discontinuation of Oral and Long-acting Injectable Antipsychotics in Clinically Stabilized Patients with Schizophrenia: A Re-analysis of Individual Participant Data.
Schizophr Bull2022https://conductscience.org/library/papers/34355232PubMed
31487433Brexpiprazole has a low risk of dopamine D2 receptor sensitization and inhibits rebound phenomena related to D2 and serotonin 5-HT2A receptors in rats.Neuropsychopharmacol Rep2019https://conductscience.org/library/papers/31487433PubMed
28360793Withdrawal-Emergent Dyskinesia and Supersensitivity Psychosis Due to Olanzapine Use.Noro Psikiyatr Ars2016https://conductscience.org/library/papers/28360793PubMed
27371498Antipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanisms.J Psychopharmacol2016https://conductscience.org/library/papers/27371498PubMed
27213069Late-Onset Mania in a Patient with Movement Disorder and Basal Ganglia Calcifications: A Challenge for Diagnosis and Treatment.Case Rep Psychiatry2016https://conductscience.org/library/papers/27213069PubMed
26788394Severe Relapsing Clozapine-Withdrawal Catatonia.Case Rep Psychiatry2015https://conductscience.org/library/papers/26788394PubMed
26694375Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia.Int J Mol Sci2015https://conductscience.org/library/papers/26694375PubMed
26346901Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism.CNS Drugs2015https://conductscience.org/library/papers/26346901PubMed
26049127Adolescent olanzapine sensitization is correlated with hippocampal stem cell proliferation in a maternal immune activation rat model of schizophrenia.Brain Res2015https://conductscience.org/library/papers/26049127PubMed
25735995Dopamine supersensitivity psychosis and dopamine partial agonist: a retrospective survey of failure of switching to aripiprazole in schizophrenia.J Psychopharmacol2015https://conductscience.org/library/papers/25735995PubMed
25478273Supersensitivity psychosis and its response to asenapine in a patient with delusional disorder.Case Rep Psychiatry2014https://conductscience.org/library/papers/25478273PubMed
24942467Differential effects of intermittent versus continuous haloperidol treatment throughout adolescence on haloperidol sensitization and social behavior in adulthood.Prog Neuropsychopharmacol Biol Psychiatry2014https://conductscience.org/library/papers/24942467PubMed
24467943Antipsychotic dosing: found in translation.J Psychiatry Neurosci2014https://conductscience.org/library/papers/24467943PubMed
24103641Time-dependence of risperidone and asenapine sensitization and associated D2 receptor mechanism.Behav Brain Res2013https://conductscience.org/library/papers/24103641PubMed
23983951Drug-induced supersensitivity psychosis revisited: characteristics of relapse in treatment-compliant patients.Ther Adv Psychopharmacol2012https://conductscience.org/library/papers/23983951PubMed
23821039Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.CNS Drugs2013https://conductscience.org/library/papers/23821039PubMed
23686527Case reports of neuroleptic malignant syndrome in context of quetiapine use.Psychiatr Q2013https://conductscience.org/library/papers/23686527PubMed
22732209Parametric studies of antipsychotic-induced sensitization in the conditioned avoidance response model: roles of number of drug exposure, drug dose, and test-retest interval.Behav Pharmacol2012https://conductscience.org/library/papers/22732209PubMed
22249643Adolescent female with withdrawal psychosis following abrupt termination of ziprasidone.Eur Child Adolesc Psychiatry2012https://conductscience.org/library/papers/22249643PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
DRD21813PubTator's text mininghttps://conductscience.org/library/genes/1813

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20147573

GET https://conductscience.org/api/papers/v1/20147573/authors